Trial intelligence / Profile preview

Effect of Hyaluronidase on IOP During Cataract Surgery

NCT03266406Unknown

Sponsor
Assiut University
Start
Sep 2017
Primary completion
Sep 2018
Modality
Therapeutic Enzymes
01

Overview

Single-arm trial of hyaluronidase in cataract, sponsored by Assiut University. Primary endpoint: Reduction in Intraocular Pressure at 10 months. Status: unknown.

02

Drugs

hyaluronidase
03

Conditions

cataract

Beyond the preview

Go deeper on NCT03266406.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03266406.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call